Document is current
Any future updates will be listed below
-
Authors
Kwon, Yohan
Kim, Eung Tae
Cho, Soo Buem https://orcid.org/0000-0001-5762-7064
Lee, Jae Hwan
Shim, Dong Jae
-
Funding
Funding for this research was provided by:
Reyon Pharmaceutical Co. and Genoss Co., Ltd. (n/a)
- License Information
-
More Information
Article History
Received: 11 September 2021
Accepted: 24 August 2022
First Online: 15 September 2022
Declarations
:
: Each IRB approved the trial of the enrolled institutes (Catholic University of Korea IRB approval number: XC20DIDS0096, Hanyang University Guri Hospital IRB approval number: HYGuri 2020-07-005, Ajou University Hospital IRB approval number: AJIRB-MED-INT-20-516, Seoul National University Bundang Hospital IRB approval number: B-2004/608-003, Ewha University Seoul Hospital IRB approval number: SEUMC 2020-07-022-009). In addition, written informed consent will be obtained from the participants. This study will be performed according to the ethical standards of the Declaration of Helsinki.
: No identifiable personal data will be published.
: The authors declare that they have no competing interests.
